Connor, Clark & Lunn Investment Management Ltd. Cidara Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$0.68 - $0.97 $8,408 - $11,994
-12,365 Reduced 3.76%
316,835 $250,000
Q3 2023

Nov 13, 2023
BUY
$0.77 - $1.16 $6,493 - $9,782
8,433 Added 2.63%
329,200 $309,000
Q2 2023

Aug 10, 2023
BUY
$1.01 - $1.42 $323,974 - $455,489
320,767 New
320,767 $362,000
Q1 2022

May 12, 2022
SELL
$0.67 - $1.39 $59,024 - $122,454
-88,097 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$1.18 - $2.18 $40,905 - $75,571
34,666 Added 64.88%
88,097 $112,000
Q3 2021

Nov 12, 2021
BUY
$1.48 - $2.35 $79,077 - $125,562
53,431 New
53,431 $120,000
Q4 2020

Feb 16, 2021
SELL
$1.99 - $3.25 $39,340 - $64,249
-19,769 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$2.85 - $4.1 $68,781 - $98,949
-24,134 Reduced 54.97%
19,769 $56,000
Q2 2020

Aug 13, 2020
SELL
$2.39 - $4.0 $16,397 - $27,444
-6,861 Reduced 13.52%
43,903 $162,000
Q1 2020

May 13, 2020
BUY
$1.74 - $4.26 $47,456 - $116,187
27,274 Added 116.11%
50,764 $125,000
Q4 2019

Feb 12, 2020
BUY
$1.77 - $3.84 $41,577 - $90,201
23,490 New
23,490 $90,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email